baber/WOPTO huggingface dataset:
Patent NZ-524377-A (NZ)
Title: Cleaning a gas stream using a biocide containing liquid
Inventor: STEWART SHAWN ALAN
IPC: B01D53/77
Filed: 2001-07-24
Abstract: A gas purification system 10 for eliminating a percentage of contaminants in a gas stream or gaseous body such as air or a gas exhaust stream, particularly useful for combating sick building syndrome (SBI) and building related illness (BRI).. While the gas stream or gaseous body moves through the scrubber unit 12, it contacts a spray or mist of biocide containing liquid 20 from a plurality of spray nozzles 18 so as to eliminate, in whole or in part, the contaminants (for example dust, smoke particles, viruses or bacteria) from the gas stream. The biocide containing liquid is typically an aqueous solution, suspension, or emulsion comprising hydrogen peroxide (H2O2) in combination with a catalyst for enhancing the activity thereof, the catalyst preferably comprising a superoxidedismutase formed from the combination of elemental copper (Cu), silver (Ag), manganese (Mn) and zinc (Zn).
Patent NZ-532723-A (NZ)
Title: Olefins production process
Inventor: FONT FREIDE JOSEPHUS JOHANNES
IPC: C10G9/00
Filed: 2002-11-05
Abstract: Disclosed is a process for the production of olefins comprising passing a synthetic naphtha to a steam cracker in which at least a portion of the synthetic naphtha is converted to olefins wherein the synthetic naphtha is a combined synthetic naphtha stream produced from a process comprising: a) contacting a synthesis gas stream at an elevated temperature and pressure with a Fischer-Tropsch catalyst in a Fischer-Tropsch reactor to generate a hydrocarbon product stream; b) separating the hydrocarbon product stream to provide at least one lighter fraction and at least one heavier fraction; c) subjecting at least a portion of the heavier fraction to hydrocracking and/or hydroisomerisation in a hydroprocessing reactor to produce an upgraded hydrocarbon product stream; d) combining the lighter fraction with the upgraded hydrocarbon product stream to produce a combined hydrocarbon stream; and e) fractionating at least a portion of the combined hydrocarbon stream to produce the combined synthetic naphtha stream.
Patent NZ-533287-A (NZ)
Title: The synthesis of the antihistamine, loratadine, from 2-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)-3-methylpyridine
Inventor: CANNATA VINCENZO
IPC: C07D401/06
Filed: 2002-10-29
Abstract: A process and oxazolinic intermediates for the preparation of 4-(8-chloro-5,6-dihydro-11H-benzo-[5,6]-ciclohepta-[1,2-b]-pyridin-11-ylidene)-1-piperidinecarboxylic acid ethyl ester (loratadine) is described. The process starts from 2-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)-3-methyl-pyridine, an intermediate to obtain loratadine. 2-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)-3-methyl-pyridine is condensed with 3-chloro-benzyl-chloride and the resultant product is treated with Grignard reagent of 4-chloro-N-methyl-piperidine. [3-(2-(3-chloro-phenyl)-ethyl]-pyridin-2-yl]-1-(methyl-piperidin-4-yl)-methanone is obtained for subsequent hydrolysis. Starting from this last compound it is possible to obtain loratadine with known methods.
Patent NZ-537975-A (NZ)
Title: Method of producing coronary vasodilation without peripheral vasodilation comprising administering at least 10 mcg of at least one A2A receptor agonist
Inventor: BELARDINELLI LUIZ
IPC: A61K31/7076
Filed: 2003-07-29
Abstract: Use of a radionuclide and an adenosine A2A receptor agonist for the manufacture of a composition for use in myocardial perfusion imaging, wherein the composition is adapted to administer the radionuclide and the adenosine A2A receptor agonist prior to examination of the myocardium for areas of insufficient blood flow.
Patent NZ-538727-A (NZ)
Title: Manufacturing process for NO-donating compounds such as NO-donating diclofenac
Inventor: ANDERSSON JOHAN
IPC: A61K31/216
Filed: 2003-09-18
Abstract: The disclosure relates to a new process for the preparation of NO-donating compounds using a sulfonated intermediate. The disclosure also relates to new intermediates prepared therein suitable for large scale manufacturing of NO-donating compounds. The disclosure further relates to the use of the new intermediates for the manufacturing of pharmaceutically active NO-donating compounds. The disclosure further relates to a substantially crystalline form of NO-donating NSAIDs, especially 2-[2-(nitrooxy)ethoxy]ethyl {2-[(2,6-dichlorophenyl)amino]phenyl}acetate, the preparation thereof and to pharmaceutical formulations containing said crystalline form and to the use of said crystalline form in the preparation of a medicament that is suitable for the treatment of pain and/or inflammation.
Patent NZ-539284-A (NZ)
Title: Buccal, polar and non-polar spray or capsule containing drugs for treating pain
Inventor: DUGGER HARRY A
IPC: A61K9/12
Filed: 2003-08-27
Abstract: Disclosed is a propellant free buccal spray composition for transmucosal administration of a pharmacologically active compound comprising: an active compound in an amount of between 0.001 and 60 percent by weight of the total composition selected from the group consisting of anti-opioid agents, anti-migraine agents, pain control agents, anaesthetics, and mixtures thereof; and a polar solvent in an amount between 30 and 99 percent by weight of the total composition; wherein the anti-opioid agent is selected from the group consisting of nalmefene, cholecystokinin, nociceptin, neuropeptide FF, oxytocin, vasopressin, and mixtures thereof; the anti-migraine agent is selected from the group consisting of frovatriptan, zolmitriptan, rizatriptan, almotriptan, eletriptan, naratriptan, ergotamine, diethylergotamine, and mixtures thereof; and the pain control agent is selected from the group consisting of alfentanil, butorphanol, codeine, dezocine, fentanyl, hydrocodone, hydromorphone, levorphanol, meperidine, methadone, morphine, nalbuphine, oxycodone, oxymorphone, propoxyphene, pentazocine, sufentanil, tramadol, and mixtures thereof. Also disclosed are buccal aerosol sprays using polar and non-polar solvent which provide biologically active compounds for rapid absorption through the oral mucosa, resulting in fast onset of effect. The disclosed buccal polar compositions comprise formulation I: aqueous polar solvent, active compound, and optional flavoring agent; formulation II: aqueous polar solvent, active compound, optionally flavoring agent, and propellant; formulation III: non-polar solvent, active compound, and optional flavoring agent; and formulation IV: non-polar solvent, active compound, optional flavoring agent, and propellant.
Patent NZ-545117-A (NZ)
Title: Doorstop for limiting the opening travel of a door
Inventor: RILEY RICHARD ARNOLD
Filed: 2006-02-03
Abstract: Doorstop mounting 8 is fixed to a door frame head 8 by screws 6. A door-engaging element 3 projects outwardly to engage the door 4 which is mounted to the frame jamb 5 via hinges 7, when moved from a closed position (shown) to an open position.
Patent NZ-545211-A (NZ)
Title: Matrix metalloproteinase inhibitors
Inventor: GAINES SIMON
IPC: C07D403/10
Filed: 2004-09-10
Abstract: Disclosed are pentanoic acid derivatives of formula (Ia) and (Ib), wherein the variables are as defined in the specification, processes for their preparation, pharmaceutical formulations containing them and their use as inhibitors of matrix metallproteinase enzymes (MMPs).
Patent NZ-548388-A (NZ)
Title: Valve for inflatable chamble of medical device
Inventor: DRECHSLER STEVEN
Filed: 2006-07-07
Abstract: A medical device such as an ostomy appliance (10) has an inflatable seal (12) for sealing an opening in a patient's body. A non-return valve is provided at an inlet port (22) for admitting inflation fluid into the inflatable seal and for preventing escape of the inflation fluid. The non-return valve comprises a film panel (26) having a first portion (26a) attached to a wall portion (27), and a second portion (26b) that is unattached to the wall portion to provide a valve function. The second portion lifts from, or seals against, the wall portion in response to a differential fluid pressure acting on the second portion. The wall portion may be a second film panel (28), or an underlying substrate.
Patent NZ-548793-A (NZ)
Title: Amide derivatives, process for preparation thereof and use thereof as insecticide
Inventor: YOSHIDA KEI
IPC: A01N43/60
Filed: 2004-12-24
Abstract: Disclosed is a compound of Formula (1), wherein A1-4 are each C, N, or N(O), G1 and G2 are each O or S, each X is hydrogen, halogen, C1-C3 alkyl, or trifluoromethyl, n is between 0 and 4, Q1 is an optionally substituted phenyl, naphthyl, or heterocyclic group, Q2 is a phenyl or heterocyclic group with one or more substituents, and wherein the other substituents are as described in the specification. Also disclosed is an intermediate of formula (4), wherein the substituents are the same as in the compound, and Hal is Cl or Br. Also disclosed is the use of the compound as an insecticide, and for protecting crops.
Patent NZ-549705-A (NZ)
Title: Animal production
Inventor: LEDGARD STEWART FRANCIS
Filed: 2006-09-05
Abstract: A method of increasing animal production by introducing a nitrification inhibitor into the digestive tract of a non-human animal, which affects the conversion of nitrogen containing compounds in animal waste, once the waste has been excreted from the animal. A preferred embodiment is a sustained slow release device administered orally to grazing animals with targeted delivery to the digestive tract. Other embodiments include animal feed and water trough applications.
Patent NZ-550500-A (NZ)
Title: Recycling 2,6-naphthalenedicarboxlic acid (2,6-NDA) contained in polyethylene naphthalate in a process to produce diesters
Inventor: MCMAHON ROSEMARY F
IPC: C07C67/08
Filed: 2005-05-09
Abstract: Disclosed is a process for preparing a dialkylester of a naphthalenedicarboxylic acid, said process comprising: directing a liquid phase reaction mixture comprising a C1-6 alcohol, a naphthalenedicarboxylic acid, a dialkylester of a naphthalenedicarboxylic acid, and a polyethylene naphthalate containing material, at a temperature range of about 500 F to about 700 F, and at a pressure in the range of about 5 to about 250 atmospheres absolute, through series arranged reaction zones while introducing a naphthalenedicarboxylic acid, a polyethylene naphthalate containing material, and a C1-6 alcohol to an upstream reaction zone, agitating at least one reaction zone, and removing a product comprising a dialkylester formed by the reaction of the naphthalenedicarboxylic acid and the polyethylene naphthalate containing material with the C1-6 alcohol from a downstream reaction zone. Also disclosed is a dialkylester of a naphthalenedicarboxylic acid prepared by the above process.
Patent NZ-551306-A (NZ)
Title: Device and method for inserting positioning and removing an implant
Inventor: KMIEC STANLEY J
IPC: A61B17/58
Filed: 2005-04-21
Abstract: A device and method for implanting a bone implant is disclosed. The device includes an impacting body, a shaft, and a locking mechanism. The impacting body has a length and a first longitudinal axis, the shaft has a proximal end, a distal end and a second longitudinal axis, where the distal end of the shaft is coupled to the impacting body in such as way so as to permit the shaft to pivot with respect to the impacting body in an operative configuration. The locking mechanism has a first and a second operating position. The first operating position permits the shaft to pivot with respect to the impacting body, and the second operating position prevents the shaft from pivoting with respect to the impacting body. The impacting body includes a channel sized and shaped to slidably receive an implant guide coupled to an implant to be inserted in a bone. The channel extends the entire length of the impacting head in a direction that is substantially perpendicular to an axis of the shaft in the second position so that the impacting body may be slid along the implant guide to impact an abutting surface thereof to drive the implant into the bone.
Patent NZ-551860-A (NZ)
Title: Use of lactic acid bacteria for decreasing gum bleeding and reducing oral inflammation
Inventor: CONNOLLY EAMONN
IPC: A61K9/68
Filed: 2005-06-14
Abstract: Disclosed is a method for selecting a lactic acid bacterial strain and producing a composition for external administration to a human, comprising the steps of: a) selecting and cultivating a strain of Lactobacillus reuteri; b) evaluating the inhibitory activity against periodontal disease-causing bacteria species and the adhesion capabilities to oral mucins of said lactobacillus strains; c) evaluating the anti-inflammatory capabilities of a conditioned medium obtained from a culture of said stains; d) evaluating the vitamin K production capabilities of said strains; and e) selecting the strains exhibiting good anti-microbial, anti-inflammatory and oral mucin adhesion properties and having the ability to produce vitamin K. Also disclosed is a product comprising cells of at least one strain of Lactobacillus reuteri selected from the group consisting of Lactobacillus reuteri "Prodentis" (ATCC PTA-5289), Lactobacillus reuteri FJ3 (ATCC PTA-5290) and Lactobacillus reuteri (ATCC PTA-55730), said strains having antimicrobial, anti-inflammatory and oral mucin adhesion properties and having the ability to produce vitamin K and the use of the composition for decreasing gum bleeding and reducing gingivitis.
Patent NZ-568859-A (NZ)
Title: Magnet holder for permanent magnet rotors with a clamping action on the magnet when attached to the rotor
Inventor: PABST OTTO
IPC: H02K1/27
Filed: 2006-09-27
Abstract: A magnet holder (2) as part of the rotor of a rotating machine such as a wind generator is disclosed. The rotating machine comprises a stator and a rotor with a rotor body (1). A plurality of magnet holders (2) are mounted on the rotor body (1), the magnet holders (2) each receiving a magnet assembly (20). Each magnet holder (2) grips its associated magnet assembly (20) with two opposed claws (3) connected by a bridge (5). A first seat (6) for the magnet assembly (20 is formed on one side of the bridge by the claws (3) and a second seat (8) is formed on another side of the bridge (5) by terminal expansions of the claws creating a pair of wedges (10). A tightening wedge (9) applies a force to the wedges (10) pushing them apart when tightened and drawn to the rotor body (1) by a fastener. The force causing the claws (3) to pivot about the bridge (5), applies compressive force at opposite ends of the claws (3), thereby gripping the magnet assembly (20). The magnet holders (2) may be formed from aluminium.
Patent NZ-572331-A (NZ)
Title: Pedestal for a sailing boat with selectable gear ratios
Inventor: OTTEMANN WILLIAM C
IPC: B63H9/10
Filed: 2008-10-28
Abstract: Disclosed is a pedestal (1) for a sailing boat. The pedestal includes a casing (2) inside of which is at least one driving wheel (11a, 11b) associated with a motion input shaft (3), at least one driven wheel (12a, 12b) associated with a motion output shaft (4) and at least one motion transmission element (13a, 13b) which is a chain or belt connecting the driving wheel (11a, 11b) to the driven wheel (12a, 12b). Also included within the casing is a speed variation system to vary the rotation speed of the motion output shaft (4) with respect to that of the motion input shaft (3).
Patent NZ-575875-A (NZ)
Title: Catheter for stomach drainage and jejunal nutrient supply
Inventor: WOLKENSTORFER REINHOLD
IPC: A61J15/00
Filed: 2007-10-18
Abstract: Disclosed is a catheter for supplying nutriments to the small intestine providing improved position maintenance in the small intestine and improving visibility of jejunal probes. The catheter for providing fluid communication with the small intestine of a patient for nutriment supply during enteral feeding, comprises a tube defining a lumen, to be inserted into the small intestine of a patient, where the outer extent of the tube is adapted via use of a pigment of dye to reflect visible light having a wavelength from 440 nm to 500 nm and absorb visible light having a wavelength greater than 500 nm.
Patent NZ-578502-A (NZ)
Title: Method of identifying GLP-1 secretagogues
Inventor: CHU ZHI-LIANG
IPC: A61K31/00
Filed: 2006-01-09
Abstract: Provided are ex vivo methods of identifying GLP-1 secretagogues, comprising determining whether the test compound which stimulates GPR119 receptor also stimulates GLP-1 secretion from mammalian enteroendocrine cells or raises level of GLP-1 in blood. Also disclosed are in vitro methods for identifying GPR119 agonists having the effect of GLP-1 secretagogues. (62) Divided Out of 556219
Patent NZ-578626-A (NZ)
Title: Floating dispersant paste
Inventor: NEDWED TIMOTHY J
IPC: C09K23/06
Filed: 2007-12-07
Abstract: An oil spill treatment agent comprising: a viscous dispersant liquid formulated to disperse oil floating on the surface of a body of water, wherein the viscous dispersant liquid is opaque, has a density between about 0.80 grams per milliter (g/ml) and about 1.02 (g/ml) and a viscosity between about 1,000 centipoise (cP) and about 10,000cP and wherein the viscous dispersant liquid comprises sorbitan monooleate, polyoxyethylene sorbitan monooleate, polyoxyethylene sorbitan trioleate, and an alkali metal salt of dioctyl sulfosuccinate. Also disclosed is a method for manufacturing an oil spill agent and a method of dispersing oil on a body of water.
Patent NZ-587283-A (NZ)
Title: Masonry with vertical reinforcing bars where vertical sliding movement of the upper end of the bar is allowed
Inventor: CLEAR LIAM
IPC: E04B2/24
Filed: 2009-02-04
Abstract: A masonry infill 50 in a load bearing structure, comprises courses of hollow masonry units 1 arranged to define a cavity 3 extending therethrough filled with reinforced cementitious material e.g. reinforced concrete. A lower end of the concrete reinforcement 2 is secured to a load bearing support 16. A body 6 is secured to the load bearing structure and receives an upper end of the concrete reinforcement so as to permit longitudinal sliding movement of the reinforcement upper end in the body, whilst constraining movement of the concrete reinforcement in a direction transversely of the infill.
Patent NZ-589637-A (NZ)
Title: Filtration media
Inventor: COULSON STEPHEN
IPC: B01D39/20
Filed: 2009-06-01
Abstract: 589637 A fibrous filtration media such as an electrostatic filtration media, whose fibre surfaces have been modified by exposure to a plasma deposition process so as to deposit a polymeric coating thereon.
Patent NZ-590177-A (NZ)
Title: Use of pyrimidylaminobenzamide derivatives for the treatment of fibrosis
Inventor: BUCHDUNGER ELISABETH
IPC: A61P11/00
Filed: 2009-07-14
Abstract: Disclosed is the use of 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-N-[5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl] benzamide or of a pharmaceutically acceptable salt thereof for the preparation of a pharmaceutical composition for the treatment of fibrosis, wherein the fibrosis is selected from pulmonary fibrosis, hepatic fibrosis and scleroderma, which is mediated by DDR1 (discoidin domain receptor 1) or DDR2 (discoidin domain receptor 2) kinase activity.
Patent NZ-592374-A (NZ)
Title: Bottle crusher with rotating rattling hammer
Inventor: BARNETT TIMOTHY JAMES FULTON
IPC: B02C13/02
Filed: 2011-04-20
Abstract: 592374 A crushing device incorporating a crushing assembly (11) and a casing (10), such that the centrelines of the crushing assembly and casing are coincident, the crushing assembly including at least two assembly plates (12, 12a, 12b), an assembly shaft (13), at least one support shaft (14, 15) and at least one impacting means (25). Each assembly plate is mounted onto, and spaced along, the assembly shaft perpendicular to a centreline of the assembly shaft. The or each support shaft lies parallel to, but separated from the assembly shaft. The or each the support shaft is driveably connected to the assembly shaft by each assembly plate. The or each impacting means includes a mounting hole (26) through which one support shaft passes, the mounting hole having a minimum clearance from the outside inscribed circle diameter of the support shaft of 2mm. The clearance between the assembly plates and the inside edge of the casing is between about 60 mm and 68mm. The mounting hole is dimensioned and configured to maintain a minimum clearance between the impacting means and an inner surface of the casing of about 50mm.
Patent NZ-595291-A (NZ)
Title: Combinations of meningococcal factor h binding protein and pneumococcal saccharide conjugates
Inventor: RUGGIERO PAOLO
IPC: A61K38/16
Filed: 2010-03-24
Abstract: 595291 Discloses an immunogenic composition comprising a conjugated pneumococcal capsular saccharide and two different meningococcal factor H binding protein (fHBP) polypeptides, wherein the fHBP polypeptides are not in the form of meningococcal outer membrane vesicles (OMVs). A method using the composition to raise immune responses against both N. meningitidis and S. pneumonia and processes for preparing the immunogenic composition.
Patent NZ-598262-A (NZ)
Title: Heat shock protein binding compounds, compositions, and methods for making and using same
Inventor: CHIOSIS GABRIELA
IPC: A61K31/54
Filed: 2010-08-17
Abstract: Disclosed is a compound represented by the general formula (I) or (I’) or a pharmacologically acceptable salt thereof; pharmaceutical compositions containing at least one of these compounds; methods of making at least one of these compounds; methods of using at least one of these compounds for treating and/or preventing various cancers and/or proliferation disorders; methods of using at least one of these compounds for monitoring the effectiveness of an anticancer therapy against various cancers. In one embodiment, the subject matter relates to compounds that bind with a level of specificity to heat shock protein 70 (Hsp70). In another embodiment, the subject matter relates to compounds that bind with a level of specificity to inhibit both heat shock protein 70 (Hsp70) and heat shock cognate protein 70 (Hsc70).
Patent NZ-598724-A (NZ)
Title: Soybean transgenic event mon 87708 and methods of use thereof
Inventor: BRINKER RONALD J
IPC: A23L11/00
Filed: 2010-08-26
Abstract: Disclosed is a recombinant DNA molecule comprising a nucleotide molecule comprising a nucleotide sequence selected from the group consisting of sequences such as ttgatctcca tgagccattt agtctcacct tcaaacactg atagtttaaa ctgaaggcgg and tcattgctga tccatgtaga tttcccggac tttagctcaa aatgcatgta tttattagcg, and complements thereof. Also disclosed is the said DNA molecule, wherein the DNA molecule is derived from soybean event MON 87708 and a representative sample has been deposited as ATCC PTA-9670.